RA

Rosalind Advisors Portfolio holdings

AUM $283M
1-Year Est. Return 91.7%
This Quarter Est. Return
1 Year Est. Return
+91.7%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$207M
AUM Growth
+$1.42M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
43
New
Increased
Reduced
Closed

Top Buys

1
+$13.2M
2
+$7.77M
3
+$5.02M
4
DCTH icon
Delcath Systems
DCTH
+$4M
5
FENC icon
Fennec Pharmaceuticals
FENC
+$2.18M

Top Sells

1
+$8.6M
2
+$5.58M
3
+$4.31M
4
IDYA icon
IDEAYA Biosciences
IDYA
+$3.97M
5
VSTM icon
Verastem
VSTM
+$2.49M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TLPH icon
26
Talphera
TLPH
$58.3M
$922K 0.44%
2,003,939
BFRI icon
27
Biofrontera
BFRI
$8.72M
$695K 0.33%
976,448
+332,055
KURA icon
28
Kura Oncology
KURA
$975M
$577K 0.27%
100,000
OVID icon
29
Ovid Therapeutics
OVID
$92.6M
$165K 0.08%
+500,000
ABEO icon
30
Abeona Therapeutics
ABEO
$228M
– –
-1,805,817
CADL icon
31
Candel Therapeutics
CADL
$255M
– –
0
COGT icon
32
Cogent Biosciences
COGT
$4.78B
– –
-248,285
CRNX icon
33
Crinetics Pharmaceuticals
CRNX
$4.05B
– –
0
INMB icon
34
INmune Bio
INMB
$37.8M
– –
0
KPRX icon
35
Kiora Pharmaceuticals
KPRX
$7.94M
– –
-250,059
LXRX icon
36
Lexicon Pharmaceuticals
LXRX
$541M
– –
0
NUVB icon
37
Nuvation Bio
NUVB
$1.67B
– –
-2,451,500
OPTN
38
DELISTED
OptiNose
OPTN
– –
-256,190
QQQ icon
39
Invesco QQQ Trust
QQQ
$387B
– –
0
SPY icon
40
SPDR S&P 500 ETF Trust
SPY
$667B
– –
0
XNTK icon
41
State Street SPDR NYSE Technology ETF
XNTK
$1.43B
– –
0
ATYR
42
aTyr Pharma
ATYR
$73.8M
– –
0
ACOG
43
Alpha Cognition
ACOG
$124M
– –
-104,836
1
2